These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34115519)

  • 1. Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective.
    Rahman SMK; Uyama T; Hussain Z; Ueda N
    Annu Rev Nutr; 2021 Oct; 41():177-202. PubMed ID: 34115519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and related
    Tsuboi K; Uyama T; Okamoto Y; Ueda N
    Inflamm Regen; 2018; 38():28. PubMed ID: 30288203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids measurement in human saliva as potential biomarker of obesity.
    Matias I; Gatta-Cherifi B; Tabarin A; Clark S; Leste-Lasserre T; Marsicano G; Piazza PV; Cota D
    PLoS One; 2012; 7(7):e42399. PubMed ID: 22860123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine.
    Artmann A; Petersen G; Hellgren LI; Boberg J; Skonberg C; Nellemann C; Hansen SH; Hansen HS
    Biochim Biophys Acta; 2008 Apr; 1781(4):200-12. PubMed ID: 18316044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical endocannabinoid-like compounds and their regulation by nutrients.
    Kleberg K; Hassing HA; Hansen HS
    Biofactors; 2014; 40(4):363-72. PubMed ID: 24677570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids and nutrition.
    Hansen HS; Artmann A
    J Neuroendocrinol; 2008 May; 20 Suppl 1():94-9. PubMed ID: 18426507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review.
    Laleh P; Yaser K; Alireza O
    J Cell Physiol; 2019 Jun; 234(6):7893-7902. PubMed ID: 30537148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.
    Ueda N; Tsuboi K; Uyama T
    FEBS J; 2013 May; 280(9):1874-94. PubMed ID: 23425575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endocannabinoids and their analogues in obesity and eating disorders.
    Gaetani S; Kaye WH; Cuomo V; Piomelli D
    Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.
    Iannotti FA; Di Marzo V; Petrosino S
    Prog Lipid Res; 2016 Apr; 62():107-28. PubMed ID: 26965148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans.
    Fuss J; Bindila L; Wiedemann K; Auer MK; Briken P; Biedermann SV
    J Sex Med; 2017 Nov; 14(11):1372-1379. PubMed ID: 29110806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms.
    Kaczocha M; Glaser ST; Maher T; Clavin B; Hamilton J; O'Rourke J; Rebecchi M; Puopolo M; Owada Y; Thanos PK
    Mol Pain; 2015 Aug; 11():52. PubMed ID: 26311517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
    Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
    J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players.
    Lambert DM; Muccioli GG
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):735-44. PubMed ID: 18089956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleic acid-derived oleoylethanolamide: A nutritional science perspective.
    Bowen KJ; Kris-Etherton PM; Shearer GC; West SG; Reddivari L; Jones PJH
    Prog Lipid Res; 2017 Jul; 67():1-15. PubMed ID: 28389247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system in the adipose organ.
    Jung KM; Lin L; Piomelli D
    Rev Endocr Metab Disord; 2022 Feb; 23(1):51-60. PubMed ID: 33387286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner.
    Ramírez-López MT; Vázquez M; Lomazzo E; Hofmann C; Blanco RN; Alén F; Antón M; Decara J; Arco R; Orio L; Suárez J; Lutz B; Gómez de Heras R; Bindila L; Rodríguez de Fonseca F
    PLoS One; 2017; 12(3):e0174307. PubMed ID: 28346523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.